baber/WOPTO huggingface dataset:
Patent JP-2754067-B2 (JP)
IPC: A61F2/06
Filed: 1990-01-12
Granted: 1998-05-20
Abstract: PURPOSE:To easily treat the hole of the affected part in the body cavity without performing celiotomy or thoracotomy by forming a medical body wall hole obturator jig having a flange part provided to one end or both ends thereof from a shape memory resin having shape recovery temp. of 20-70 deg.C. CONSTITUTION:A body wall hole obturator jig is composed of a shape memory resin having shape recovery temp. of 20-70 deg.C, pref., 30-50 deg.C and deformed into a contracted shape suitable for insertion at the shape recovery temp. or lower and restored to the original molded shape having flange parts 1, 2 at both ends of the cylindrical central part thereof at the shape recovery temp. or higher. The medical body wall hole obturator jig 11 thus formed is mounted to the guide wire 13 inserted in the artery vessel part of the affected part between the main artery and the pulmonary artery from the vein of the femur part so that the guide wire 13 passes through the hole 16 of said jig 11 and inserted up to the affected part while pushed by a catheter 12 to be fitted in the hole of the affected part and, for example, a physiological saline solution of 45 deg.C is allowed to flow in the catheter 12 from a lumen 15 and the shapes of the flange parts 1, 2 are restored to fix the jig 11 to the hole of the affected part. By this method, the hole of the affected part in the body cavity can be easily treated.
Patent AU-681737-B2 (AU)
Title: Parathyroid hormone formulation
Inventor: HOLTHUIS JOSEPHUS JOHANNES MAR
IPC: A61K38/29
Filed: 1994-12-16
Granted: 1997-09-04
Abstract: Described herein are preparations containing parathyroid hormone that has been stabilized with an excipient and buffering agent. Preferred preparations incorporate human PTH(1-84), mannitol as excipient and citrate as buffering agent, and are incorporated in vials as a freeze-dried powder for reconstitution to treat osteoporosis.
Patent AU-758987-B2 (AU)
Title: A film with UV-barrier properties
Inventor: HIRN THOMAS WOLFGANG FRIEDRICH
IPC: C08K5/132
Filed: 1999-11-08
Granted: 2003-04-03
Abstract: The present invention is directed to a thin packaging film made out of a thermoplastic material with anti-UV properties, characterized in that its composition further comprises a combination of at least one organic compound with at least one inorganic UV-absorbent compound, for improved barrier against UV rays, and improved transparency. Preferably, the organic compound is a benzotriazole, and the inorganic compound is micronized zinc oxide. More preferably, the material for the film further comprises a binder compound, for example a benzophenone, in order to improve the compatibility between the organic component and the base-resin. Preferably, the film thickness is below 80 mu m, more preferably below 35 mu m.
Patent AU-613618-B2 (AU)
Title: Polycyclic heterocyclic compounds, a process for their preparation and their use in human and veterinary medicine
Inventor: SHROOT BRAHAM
IPC: C07D307/92
Filed: 1988-04-29
Granted: 1991-08-08
Abstract: A polycyclic heterocyclic compound has the formula    <IMAGE>  (I) wherein n is 1 or 2, R1 l represents (i) lower alkyl, (ii) -CH2OH or (iii)   <IMAGE>  R2 represents (a) hydrogen, (b)   <IMAGE>   or (c)-OR3, R3 represents hydrogen, C1-C20 alkyl mono or polyhydroxyalkyl, aryl or aralkyl optionally substituted, the residue of a sugar or   <IMAGE>   wherein p is 1, 2, or 3, and r' and r'' represent hydrogen, lower alkyl, mono or polyhydroxyalkyl, aryl optionally substituted, amino acid residue, aminated sugar residue, or together form a heterocycle, X represents oxygen, sulfur, SO, SO2 or -NR4, Y represents CR4 or a nitrogen atom and R4 represents hydrogen or lower alkyl. This polycyclic heterocyclic compound can be used in human and veterinary medicine and especially in the topical or systemic treatment of determatologic diseases.
Patent AU-560267-B2 (AU)
Title: Dielectric and cooling fluid
Inventor: LLOYD HAROLD
IPC: H01H35/40
Filed: 1983-06-17
Granted: 1987-04-02
Abstract: Dielectric, cooling or arc-extinguishing fluids comprise a mixture of tetrachlorodifluoroethane and perchloroethylene, optionally with incorporation of a third component which is preferably trichlorotrifluoroethane. Transformer and circuit-interrupter apparatus containing such dielectric fluids are also described.
Patent AU-761054-B2 (AU)
Title: Multi-player interactive electronic game for health education
Inventor: BROWN STEPHEN J
IPC: G06F19/00
Filed: 1998-12-22
Granted: 2003-05-29
Abstract: A multi-player interactive electronic game for health education encourages inter-player communication about a health condition by correlating the players' progress. Each player manages the health of a game construct such as a game character or body region. Correlating the player's game progress is achieved through: common scoring; conditioning a player's passage to higher levels on the health management success of all players; and shared game resources, including game resources representing devices or supplies used in the care of the health condition. Applications include children' health education related to diseases such as diabetes and asthma, as well as health habits such as dental hygiene, and tobacco, alcohol and drug use.
Patent AU-664853-B2 (AU)
Title: Stabiliser system for vehicles
Inventor: SHEPHERD DONALD WELTON
IPC: B62H1/06
Filed: 1992-08-07
Granted: 1995-12-07
Abstract: A stabiliser system, primarily for supporting a pedal bicycle and its rider upright at the halt, comprises a spring-loaded telescopic arm (26) which is connected at its upper end by a pivot (21) adjacent the rear wheel spindle (12) to a bracket secured to the spindle (12). A bolt (31) pivoted to the bracket engages the gusset plate (13) to resist clockwise motion of the bracket and a gas strut (28) extends between the bracket and the arm (26). At the lower end of the arm (26) is a cross-shaft (33) carrying stabiliser wheels (34, 35). The arm can be lowered by a cable (46) to move a roller (36) on the cross-shaft beneath the tyre of the wheel (11) so that a large part of the weight of the rider is transferred to the ground through the rear wheel (11), the roller (36), the cross-shaft (33) and the stabiliser wheels (34, 35). The cable (46) is in the form of a closed loop and passes around a guide (41) on the cross-shaft, around tapered guide pulleys (77) carried by a dependent bracket (62) within which is pivoted an arm (53) carrying a shaft (56) on which there is a tyre-engaging wheel (57) and two spools (58). The bracket (62) contains a cam (67) which can be operated from the handlebars via a Bowden cable (75). To lower the arm (26), the wheel (57) is moved by the cam into engagement with the tyre of the bicycle wheel (11) to rotate the spools (58) and draw in the cable (46).
Patent AU-769612-B2 (AU)
Title: Avermectin derivatives
Inventor: OMURA SATOSHI
IPC: A61P33/00
Filed: 2000-02-09
Granted: 2004-01-29
Abstract: Avermectin derivatives having antiparasitic activity represented by the general formula (I) or salts thereof:   
wherein -X ---- Y- represents -CH=CH-, -CH 2 -C(=O)-, -CH 2 -CH 2 -, or -CH 2 CH(R 13 )-; the line  ----  between R 1  and the carbon atom at the 4''-position represents a double bond and R 1  represents (R 11 )(R 12 )C; or when -X ---- Y- represents -CH 2 -CH 2 -, the line  ----  between R 1  and the carbon atom at the 4''-position may represent a single bond and R 1  represents a carboxymethyl group or a cyanomethyl group; and the line  ----  between R 2  and the carbon atom at the 5-position represents a single or a double bond.
Patent AU-680366-B2 (AU)
Title: Multiple promoter baculovirus expression system and defective particle production
Inventor: OKER-BLOM CHRISTIAN E G
IPC: C07K14/19
Filed: 1995-07-05
Granted: 1997-07-24
Abstract: This invention relates to specifically designing and genetically engineering recombinant baculovirus for producing, in a compatible insect system, a desired protein, virus, protein hybrid, or virus hybrid. In particular aspects, this invention relates to the use of different baculovirus promoters for the ultimate purpose of constructing a recombinant baculovirus designed for the investigator's specific need. For example, the recombinant baculovirus of this invention can be designed to produce a viral pesticide. This invention also describes the construction of a genetically engineered virus or virus hybrid (e.g. animal or human pathogen) which is not capable of replicating itself but is essentially identical to the authentic pathogen in terms of structure and antigenicity. This baculovirus is constructed such that the non-structural viral genes are truncated, mutated or both and are located 3' and directly under the control of an early baculovirus gene promoter and the structural viral genes are located 3' and directly under the control of a late baculovirus gene promoter. This genetically engineered baculovirus is therefore capable of temporal regulation and successive synthesis of non-structural and structural proteins. The truncated or mutated non-structural viral genes creates the non-replicative aspect of this invention. Since the genetically produced virus or virus hybrid is essentially identical to the authentic pathogen, the product is thereby highly antigenic and potent in terms of efficacy and efficiency. This invention enables the design and constructure of a virus particle or virus hybrid with specific antigenic properties which further allows for the safe and inexpensive production of vaccines or diagnostics.
Patent AU-658667-B2 (AU)
Title: Quinoline derivative and its salts derivatives
Inventor: PETERSEN UWE
IPC: A23K20/195
Filed: 1992-09-22
Granted: 1995-04-27
Abstract: 7-(1-Pyrrolidinyl)-1,4-dihydro-4-oxo-3-quinoline-carboxylic acid and 7-(1-pyrrolidinyl)-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carboxylic derivs. of formula (I), their hydrates, acid addition salts, as well as their alkali metal, alkaline earth, silver and guanidinium salts are new; X<1> = halo; X<2> = H, NH2, 1-4C alkylamino, di(1-3C alkyl)amino, OH, 1-4C alkoxy, SH, 1-4C alkylthio, arylthio or halo; R<1> = 1-4C alkyl, 2-4C alkenyl, 3-6C cycloalkyl, 2-hydroxyethyl, 2-fluoroethyl, OMe, NH2, MeNH, EtNH or Me2N; or is Ph (opt. mono- or disubstd. by F); R<2> = H, 1-4C alkyl or (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl; R<3> = a gp. of formula (a): R<4> = 1-4C alkyl, aryl or 1-4C acyl; R<5> = H, 1-4C alkyl, OH or OMe; R<6> = H, 1-4C alkyl (opt. substd. by OH), aryl, heteroaryl, benzyl, 1-4C alkoxycarbonyl, 1-4C acyl, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl or 3-6C cycloalkyl; R<7> = H or 1-4C alkyl; R',R'' = H, Me or Ph; R''' = H or Me; Y = O, CH2, CH2CH2 or CH2O (where the bond to N may be via C as well as O); (Note: Y is not otherwise defined in claim 1). Z = O or S; A = N or CR<8>; R<8> = H, halo, Me, CN, NO2 or OH, or R<8>+R<1> = a bridge of type (b)-(d): Cpds. of formula (e) are excluded; R1 = 1-4C alkyl; R2,R3 = H or 1-4C alkyl; R4 = cyclopropyl, Ph, halophenyl, thienyl, opt. substd. by 1-4C alkyl or halo; R5 = halo. Also claimed is the S,S-configuration of a cpd. of formula (f) and its salts:A = CCl, CF or COMe.
Patent AU-776431-B2 (AU)
Title: Method for emptying a blood circuit of an apparatus for the extracorporeal treatment of blood
Inventor: PEDRAZZI RENATO
IPC: A61M1/14
Filed: 2001-01-12
Granted: 2004-09-09
Abstract: A method for emptying a blood circuit of an apparatus for the extracorporeal treatment of blood after interrupting a treatment session. The apparatus has a blood treatment device with first and second compartments separated by a semi permeable membrane, an arterial pipe connected to an inlet of the first compartment, a venous pipe connected to an outlet of the first compartment and a second end, and a used liquid circuit having a drain pipe connected to an outlet of the second compartment. The method involves the closing of the blood circuit on itself. The blood circuit includes the arterial pipe, the first compartment of the blood treatment apparatus, and the venous pipe, in order to form a closed loop circuit after the arterial and venous pipes have been disconnected from the vascular system of the patient. The blood circuit contains a liquid, which is transferred from the closed loop circuit into the used liquid circuit. The liquid transferred into the used liquid circuit is then drained using the drain pipe.
Patent AU-782545-B2 (AU)
Title: Method for enabling a file
Inventor: THOONE MARTIN
IPC: G06F1/00
Filed: 2001-03-15
Granted: 2005-08-11
Abstract: The method involves passing an equipment identifier from a local computer system to a central station, computing a new equipment identifier using a change code, specifying a first enciphered code using a key, specifying a second enciphered code using the data file identifier, passing the enciphered codes to the local system, computing the new equipment identifier, the key and data file identifier in the local system and releasing the data file. The method involves passing an equipment identifier (ID(i-1)) from a local computer system to a central station, computing a new equipment identifier (ID(i)) from the equipment number and a change code, specifying a first enciphered code (PIN) using the computed code and a key (k), specifying a second enciphered code (ACW) using the data file identifier and the key, passing the enciphered codes to the local system, computing the new equipment identifier in the local system from the stored identifier and the change code, computing the key from the first enciphered code and the equipment identifier, computing the data file identifier (AC) from the second enciphered code and the key and releasing the data file for use by the local system. Independent claims are also included for the following: a system for managing and releasing access rights to data files.
Patent AU-650186-B2 (AU)
Title: Method of terminal steam sterilization
Inventor: LIEBERT RICHARD T
IPC: A61L2/06
Filed: 1992-12-17
Granted: 1994-06-09
Abstract: A method for terminal steam sterilization of a pre-filled plastic or glass syringe or cartridge is disclosed, said method comprising the steps of: maintaining a head space in the syringe or cartridge of not exceeding about 10% volume; providing at least about 2%, preferably about 10%, leeway for the plunger therein to slide in response to pressure differential; and in the case of a plastic syringe or cartridge sterilizing the syringe or cartridge at an autoclave pressure that is less than the internal pressure of the syringe or cartridge content; or in the case of a glass syringe or cartridge sterilizing the syringe or cartridge at an autoclave pressure that is less than, equal to or greater than the internal pressure of the syringe or cartridge content. <IMAGE>
Patent AU-778603-B2 (AU)
Title: Novel odorant receptors in drosophila
Inventor: CARLSON JOHN R
IPC: C12N15/12
Filed: 2000-01-25
Granted: 2004-12-09
Abstract: The present invention provides nucleic acids and amino acids for novel olfactory receptors as well as methods for identifying olfactory receptors. More specifically, the present invention provides nucleic acids and amino acids for novel olfactory receptors in Drosophila as well as methods of using the provided nucleic acids and amino acids. In addition, this invention provides methods of identifying ligands which bind to the novel olfactory receptors as well as a variety of methods for using the ligands so identified.
Patent AU-659284-B2 (AU)
Title: A medicine dispensing device
Inventor: LEVANDER GUSTAV
IPC: A61M5/315
Filed: 1993-01-14
Granted: 1995-05-11
Abstract: PCT No. PCT/SE93/00015 Sec. 371 Date Aug. 30, 1993 Sec. 102(e) Date Aug. 30, 1993 PCT Filed Jan. 14, 1993 PCT Pub. No. WO93/14799 PCT Pub. Date Aug. 5, 1993.A medicine dispensing device including a slotted housing, a front end, a rear end, at least one threaded portion in the vicinity of the rear end, a dosage ampoule fitting in the vicinity of the front end and a discharge conduit for connection with a discharge ampoule. A hollow screw-threaded device receives the ampoule therein. The screw-threaded device is received by the rear end of the housing. The screw-threaded device includes an exterior surface provided with a threaded surface engaging the at least one threaded portion for securing the ampoule within the housing. A medicine discharge and metering device for metering and discharging the contents of the ampoule is received within the screw-threaded device and is movable in a direction of a longitudinal axis thereof. Subsequent to administering a dosage from the ampoule, the medicine discharge and metering device enables the ampoule to move rearwardly in a direction of a longitudinal axis of the housing to an extent sufficient to release the ampoule from engagement with the ampoule fitting. The ampoule, the screw-threaded device, and the discharge and metering device are thereby permitted to swing outwardly through the slotted housing, whereby the screw-threaded device is disengaged from the at least one threaded portion, thereby enabling the screw-threaded device and the discharging and metering device to move rearwardly and to return to a starting position within the housing where the screw-threaded device can receive a new ampoule through the housing.
Patent AU-770323-B2 (AU)
Title: Method and apparatus for facilitating physiological coherence and autonomic balance
Inventor: CHILDRE DOC L
IPC: A61B5/024
Filed: 2000-03-01
Granted: 2004-02-19
Abstract: Method and apparatus for determining the state of entrainment between biological systems which exhibit oscillatory behavior such as heart rhythms, respiration, blood pressure waves and low frequency brain waves based on a determination of heart rate variability (HRV) and an evaluation of the power spectrum thereof. Entrainment reflects a harmonious balance between the two branches of the autonomic nervous system within the body. This internal state of heightened physiological efficiency enhances health and promotes optimal performance. According to one embodiment a method is used to determine the entrainment level based on an entrainment parameter related to HRV. The method first determines the power distribution spectrum (PSD) and then calculates an entrainment parameter (EP), which is a measure of the power distribution in the HRV spectrum. High EP values occur when this power is concentrated within a relatively narrow range of frequencies, and lower values when the power is distributed over a broader range of frequencies. In one embodiment, an apparatus is provided for monitoring the heart beat and presenting this information via a personal computer, handheld device, or other processing means.
Patent AU-717556-B2 (AU)
Title: A foundation element, methods for the construction of prefabricated structures including these elements, particularly prefabricated tunnels, and prefabricated structures made by these methods
Inventor: MONACHINO MOSE
IPC: E02D27/02
Filed: 1997-07-16
Granted: 2000-03-30
Abstract: A foundation element in the form of a rigid monolithic prefabricated frame which includes at least two opposite containing side walls and cross-members interconnecting the two side walls so as to form a casting through-cavity between these two walls. The frame is intended to be located on the ground with the interposition of adjustable support devices and is intended to receive a hardenable fluid binder material poured into its through-cavity and adapted to spread onto the ground between this and the side walls and to fill the cavity, encapsulating the cross-members and the iron rods or other connecting members for connecting a superstructure element. Also provided are prefabricated structures including prefabricated tunnels, with foundation elements formed by means of the prefabricated frames.
Patent AU-671280-B2 (AU)
Title: Fungicidal phenylbenzamides and processes for the preparation thereof
Inventor: LATORSE MARIE-PASCALE
IPC: A01N37/38
Filed: 1993-06-30
Granted: 1996-08-22
Abstract: 1) Compounds of the phenylbenzamide family. 2) They are of formula (I): <IMAGE>  in which:   - R1 and R2, which are identical or different, are a hydrogen or halogen atom or an optionally halogenated alkyl radical, and - R3 and R4, which are identical or different, are an alkyl containing 1 to 4 carbon atoms or can form, together with the nitrogen atom which carries them, a morpholino ring.   3) Fungicides applicable in agriculture.
Patent AU-773519-B2 (AU)
Title: Process for the production of 1,2-butadiene
Inventor: STUWE ARNE
IPC: C07C7/04
Filed: 1999-08-20
Granted: 2004-05-27
Abstract: The production of 1,2-butadiene in purities of at least 85% becomes possible by means of a process in which a polymerization-inhibitor-containing C4 hydrocarbon fraction is subjected to at least one fractional distillation.
Patent AU-698667-B2 (AU)
Title: Pharmaceutical excipient having improved compressibility
Inventor: SHERWOOD BOB E
IPC: A61K9/20
Filed: 1996-01-05
Granted: 1998-11-05
Abstract: A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles and from about 0.1% to about 20% silicon dioxide particles, by weight of the microcrystalline cellulose, wherein the microcrystalline cellulose and silicon dioxide are in intimate association with each other. The silicon dioxide utilized in the novel excipient has a particle size from about 1 nanometer to about 100 microns. Most preferably, the silicon dioxide is a grade of colloidal silicon dioxide.
Patent AU-584926-B2 (AU)
Title: A binder composition which is pigmentable
Inventor: SYRIER JOHANNES LEOPOLD MARIE
IPC: C08L57/02
Filed: 1985-10-14
Granted: 1989-06-08
Abstract: A binder composition which is pigmentable comprising a mineral lubricating oil extract and a petroleum resin and/or coumarone-indene resin, characterized in that the petroleum resin and/or the coumarone-indene resin contains carboxylic acid, carboxylic acid anhydride or hydroxyl groups.
Patent AU-620966-B2 (AU)
Title: Novel n-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
Inventor: TRIVEDI BHARAT KALIDAS
IPC: A61K31/353
Filed: 1990-02-07
Granted: 1992-02-27
Abstract: Novel N-[substituted aryl]-N min -(substituted alkoxy)-urea and thiourea derivatives are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful in preventing the intestinal absorption of cholesterol and thus are useful in the treatment of hypercholesterolemia and atherosclerosis.
Patent AU-731116-B2 (AU)
Title: Method for configuring a fuzzy automatic-control device which is used for comparing a measurement signal with a pattern signal
Inventor: ADAMY JURGEN
IPC: B22D11/16
Filed: 1997-11-18
Granted: 2001-03-22
Abstract: The method according to the present invention is used for automatically configuring a fuzzy automatic-control device, in the form of generating transformation criteria. These transformation criteria preferably have change, stop, jump-back and reset rules for the individual states of the fuzzy automatic-control device that represent recognition probabilities. The method allows transformation criteria for configuring fuzzy automatic-control devices to be produced fully automatically by the arithmetic logic unit. Even if the pattern signals change frequently, the fuzzy automatic-control device can thus be reconfigured quickly, flexibly and without complications.